Fast Five Quiz: COVID-19 Pulmonary Management

Romesh Khardori, MD


August 30, 2023

COVID-19 is highly infectious because it quickly multiplies and spreads throughout the body. Many people believe that COVID-19 affects only the respiratory tract, but it is a multisystem disease. Symptomatic COVID-19 cases often have pulmonary manifestations occurring as mild, moderate, or severe. Severe COVID-19 cases can increase vascular permeability and eventually cause pulmonary edema, with diffuse alveolar damage to the lungs common to most fatalities. A wide spectrum of pulmonary manifestations directly related to the severity of acute illness, including post-exertion dyspnea, fibrotic lung lesions in high-resolution CT, reduction in diffusion capacity, and restrictive pulmonary physiology, have been reported in up to 35% of survivors.

Are you ready to identify and manage the acute and long-term consequences of this disease? Test yourself with a short quiz.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.